UnknownNot Applicable

Pancreatic Stone Protein (PSP) in Pregnant Women

Switzerland486 participantsStarted 2014-09

Plain-language summary

This prospective, single centred cohort study evaluates the physiological course of the potentially novel biomarker PSP in pregnant women as well as its predictive role in the development of inflammatory complications during pregnancy.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years * Healthy women with single pregnancy * Women with PPROM, AIS, preeclampsia, or HELLP syndrome * Patients able to provide informed consent Exclusion Criteria: * Viral (hepatitis B virus, hepatitis C virus, human immunodeficiency virus) or confirmed bacterial infections

What they're measuring

Physiological course of PSP in healthy pregnant women

Timeframe: 34 weeks

Trial details

NCT IDNCT02247297

SponsorNicole Ochsenbein

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-09

Contact for this trial

Nicole Ochsenbein, Prof. Dr.

+41 (0)44 255 11 11 nicole.ochsenbein@usz.ch

View on ClinicalTrials.gov More Pregnancy trials